Filing Details

Accession Number:
0001495800-19-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-02 16:44:19
Reporting Period:
2019-08-01
Accepted Time:
2019-08-02 16:44:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1495800 A. Gary King 320 Wakara Way
Salt Lake City UT 84108
Exec. Vp International Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-01 30,000 $26.49 164,871 No 4 M Direct
Common Stock Disposition 2019-08-01 30,000 $46.19 134,871 No 4 S Direct
Common Stock Acquisiton 2019-08-01 10,000 $23.98 144,871 No 4 M Direct
Common Stock Disposition 2019-08-01 10,000 $43.48 134,871 No 4 S Direct
Common Stock Acquisiton 2019-08-01 20,000 $19.47 154,871 No 4 M Direct
Common Stock Disposition 2019-08-01 20,000 $39.44 134,871 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-08-01 20,000 $0.00 20,000 $19.47
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-08-01 10,000 $0.00 10,000 $23.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-08-01 30,000 $0.00 30,000 $26.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,432 2021-09-13 No 4 M Direct
1,830 2022-03-07 No 4 M Direct
106,225 2021-09-17 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.